Loading…
Based on limited metadata without access to the full warning letter text, this FDA Warning Letter issued to Sublime Liquids on February 28, 2020, concerns a tobacco product company. While the specific subject line and violation details are not available in the provided metadata, the correspondence falls under FDA's tobacco product regulatory authority. Without the complete letter content, the precise nature of the compliance issues cannot be determined, but they likely relate to manufacturing, labeling, marketing, or other regulatory requirements governing tobacco products under FDA jurisdiction.